Evidence map›Paper›PMID 30410064›Full record

ArticleMolecular psychiatry2020

Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program.

Guusje Collin, Larry J Seidman, Matcheri S Keshavan, William S Stone, Zhenghan Qi, Tianhong Zhang, Yingying Tang, Huijun Li, Sheeba Arnold Anteraper, Margaret A Niznikiewicz and 4 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04010864 (Real-world Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-risk for Psychosis), which is not on this map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04010864 unknown statusnot on this map

Real-world Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-risk for Psychosis: Study Protocol for a Prospective Observational Study (SHARP-2)

Typeobservational_patient_registrySponsorShanghai Mental Health CenterRan2019 to 2022Enrolled600ConditionsClinical High-riskArmsroutine clinical treatment
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Negative symptoms are associated with modularity and thalamic connectivity in schizophrenia.European archives of psychiatry and clinical neuroscience · 2023
    Article
  16. A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk.Journal of psychiatry and brain science · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Guusje CollinDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. gcollin@bidmc.harvard.edu.
Larry J SeidmanDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Matcheri S KeshavanDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
William S StoneDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Zhenghan QiDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Tianhong ZhangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yingying TangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Huijun LiDepartment of Psychology, Florida A&M University, Tallahassee, FL, USA.
Sheeba Arnold AnteraperMcGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.
Margaret A NiznikiewiczDepartment of Psychiatry, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA.
Robert W McCarleyDepartment of Psychiatry, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA.
Martha E ShentonPsychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Jijun WangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jijunwang27@163.com.
Susan Whitfield-GabrieliMcGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.
Beth Israel Deaconess Medical Center · USMassachusetts Institute of Technology · USShanghai Mental Health Center · CNVA Boston Healthcare System · USFlorida Agricultural and Mechanical University · USHarvard University · USShanghai Jiao Tong University · CNSignature Healthcare Brockton Hospital · USUniversity of Delaware · US

Funding

Identifying mechanisms of response to therapeutic intervention in clinical high risk (CHR) for psychosis: a bridge to treatmentR01MH111448 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LI, HUIJUN, NIZNIKIEWICZ, MARGARET A · 2016 to 2023
$4.4M
Brain Maturation and Vulnerability to SchizophreniaR01MH064023 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KESHAVAN, MATCHERI S. · 2003 to 2008
$3.0M
Validating Biomarkers for the Prodrome and Transition to Psychosis in ShanghaiR01MH101052 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LI, HUIJUN, MCCARLEY, ROBERT W · 2013 to 2015
$600k
Broadening the Investigation of Psychosis Prodrome to Different Cultural GroupsR21MH093294 · NIMH · FLORIDA AGRICULTURAL AND MECHANICAL UNIV · PI LI, HUIJUN, SEIDMAN, LARRY J · 2012 to 2013
$249k
NIMH NIH HHS R01 MH064023NIMH NIH HHS R01 MH101052NIMH NIH HHS R01 MH111448NIMH NIH HHS R21 MH093294
6 · The paper itself

Abstract

The emergence of prodromal symptoms of schizophrenia and their evolution into overt psychosis may stem from an aberrant functional reorganization of the brain during adolescence. To examine whether abnormalities in connectome organization precede psychosis onset, we performed a functional connectome analysis in a large cohort of medication-naive youth at risk for psychosis from the Shanghai At Risk for Psychosis (SHARP) study. The SHARP program is a longitudinal study of adolescents and young adults at Clinical High Risk (CHR) for psychosis, conducted at the Shanghai Mental Health Center in collaboration with neuroimaging laboratories at Harvard and MIT. Our study involved a total of 251 subjects, including 158 CHRs and 93 age-, sex-, and education-matched healthy controls. During 1-year follow-up, 23 CHRs developed psychosis. CHRs who would go on to develop psychosis were found to show abnormal modular connectome organization at baseline, while CHR non-converters did not. In all CHRs, abnormal modular connectome organization at baseline was associated with a threefold conversion rate. A region-specific analysis showed that brain regions implicated in early-course schizophrenia, including superior temporal gyrus and anterior cingulate cortex, were most abnormal in terms of modular assignment. Our results show that functional changes in brain network organization precede the onset of psychosis and may drive psychosis development in at-risk youth.

Indexed as

ConnectomeAdolescentAdultChildChinaFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleProdromal SymptomsPrognosisPsychotic DisordersSchizophreniaYoung Adult

Identifiers

PMID30410064
PMCPMC6813871
OpenAlexW2899203206

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.